Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy

Epilepsia

Volumn 37, Issue 11, 1996, Pages 1128-1137

  De Bittencourt, P R M ^a   Adamolekum, B ^b   Bharucha, N ^b   Carpio, A ^b   Cossio O H ^b   Danesi, M A ^b   Dumas, M ^b   Fernandes, J G ^b   Genton, P ^b   Manreza, M L ^b   Meinardi, H ^b   Ordinario, A ^b   Senanayake, N ^b   Shakir, R ^b   Singhal, B S ^b   Sotelo, J ^b  

^a Unidade de Neurol Clin S C Ltda   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; STEROID; VALPROIC ACID;

ARTICLE; CLINICAL EXAMINATION; DRUG COST; ECONOMIC ASPECT; EPILEPSY; EPILEPTOGENESIS; HUMAN; NEUROCYSTICERCOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SERODIAGNOSIS; TROPICAL DISEASE; TROPICS;

EID: 10544235691     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb01036.x     Document Type: Article

References (72)

1. Commission on Epidemiology and Prognosis, International League Againt Epilepsy. Guidelines for epidemiology studies on epilepsy. Epilepsia 1993;34:592-6.
2. Bittencourt PRM, Gracia CM, Lorenzana P. Epilepsy and parasitosis of the central nervous system. In: Pedley TA, Meldrum BS, eds. Recent advances in epilepsy. Vol 8. Edinburgh: Churchill Livingstone, 1988:123-59.
3. Commission on Tropical Diseases of the International League Against Epilepsy. Relationship between epilepsy and tropical diseases. Epilepsia 1994;35:89-93.
4. Wadia N, Desai S, Bhatt M. Disseminated cysticercosis: new observations, including CT scan findings and experience with treatment by praziquantel. Brain 1988;111:597-614.
5. Wadia RS, Makhale CN, Kelkar AN, Grant KB. Focal epilepsy in India with special reference to lesions showing ring or disc-like enhancement on contrast computed tomography. J Neurol Neurosurg Psychiatry 1987;50:1298-301.
6. Bhatia S, Tandon PN. Solitary "microlesions" in CT: a clinical study and follow-up. Neurology (India) 1988;36:139-49.
7. Goulatia RK, Verma A, Mishra NK, Ahuja GK. Disappearing CT lesions in epilepsy. Epilepsia 1987;28:523-7.
8. Jaykumar PN, Taly AB, Mohan PK. Transient CT abnormalities following partial seizures. Acta Neurol Scand 1985;72:26-9.
9. Sethi PK, Kumar BR, Madan VS, Mohan V. Appearing and disappearing CT-scan abnormalities and seizures. J Neurol Neurosurg Psychiatry 1985;48:866-9.
10. Chandy MJ, Rajeshkhar V, Ghosh S, et al. Single small enhancing CT lesions in Indian patients with with epilepsy: clinical, radiological and pathological consideration. J Neurol Neurosurg Psychiatry 1991;54:702-5.
11. Singhal BS, Ladiwala U, Gursahani RD. Solitary ring enhancing lesion and seizure disorder in the Indian context, personal communication. Workshop: Epilepsy in the Tropics, Oslo, 1993.
12. Rajeshkar V, Prakash S, Chandy MJ. Differentiating solitary small granulomas and tuberculomas in patients with epilepsy. J Neurosurg 1993;78:402-7.
13. Scrimgeour EM, Gadjusek DC. Involvement of the central nervous system in Schistosoma mansoni and S. haemutobium infection. Brain 1985;108:102-1038.
14. Cho WJ, Kim HJ. Ocular symptoms of intracranial tumour (clinical survey of 93 Korean cases). J Korean Ophthal Soc 1964;5:35-41.
15. Fan K-J, Pezeshkpour GH. Cerebral sparganosis. Neurology 1986; 36:1249-51.
16. Feldman HA. Toxoplasmosis: review article. Pediatrics 1958;22: 559-74.
17. Stern H, Elek SD, Booth JC, Fleck DG. Microbial causes of mental retardation: the role of prenatal infections with cytomegalovirus, rubella virus and toxoplasma. Lancet 1969;ii:443-8.
18. Navia BA, Petito CK, Gold JWM, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome; clinical and neurological findings in 27 patients. Ann Neurol 1986;19:224-38.
19. Wieser HG, Wang J, Panayoutou P, et al. Incidence of epileptic seizures in AIDS patients. Epilepsia 1993;34(Suppl 12):36.
20. Ferreira FSC, Rocha LAC. Tripanosomíase africana. In: Veronesi R, ed. Doenças infecciosas e parasitárias. 7th ed. Rio de Janeiro: Guanabara-Koogan, 1982:713-23.
21. Senga P, Mayanda HF, Nzingoula S. Profile of seizures in infants and young children in Brazzaville (Congo). Ann Pediatr 1985;32: 477-80.
22. Lingam S, Marshall WC, Wilson J, Gould JM, Reinhardt MC, Evans DA. Congenital trypanosomiasis in a child born in London. Dev Med Child Neurol 1985;27:670-4.
23. Jardim E, Takayanagui OM. Epilepsia e doença de Chagas cronica. Arq Neuropsiquiatr 1981;39:32-41.
24. Roman GC. Neurology in Latin America. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in clinical practice. Boston: Butterworth-Heinemann, 1991:1888-98.
25. Vietze G. Malaria and other protozoal diseases. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Vol 35. Amsterdam: Elsevier North Holland, 1978:143-60.
26. Espinal CA, Toro G. Malaria. In: Chalem F, Escandon JE, Campos J, Esguerra R, eds. Medicina Interna. Bogota: Editorial Norma, 1986:278-88.
27. Toro G, Roman G, Navarro de Roman L. Paludismo. In: Toro G, Roman G, Navarro de Roman L, eds. Medicina interna. Bogota: Editorial Norma, 1986:278-88.
28. Fain A. Les problemes actuels de la loase. Bull WHO 1978;56: 155-67.
29. Toussaint D, Danis P. Retinopathy in generalised Loa-loa filariasis. Arch Ophthalmol 1965;74:470-6.
30. Mazzoti L. Presencia de microfilariasis de Onchocerca volvulus en al liquids cefalorraquides de enfermos tratados con hetrazan. Rev Inst Salubr Enferm Trop Mex 1959:19:1-5.
31. Negesse Y, Lanoie OO, Nearsh Ro, Connor DH. Loasis: calabar swellings and involvement of deep organs. Am J Trop Med Hyg 1985;34:537-46.
32. Lumsden WHR. Trypanosomiasis. Br Med Bull 1972;28:34-8.
33. Neves J. Tripanosomíase africana. In: Neves J. ed. Diagnóstico e tratamento das doenĉas infectuosas e parasitárias. 2nd ed. Rio de Janeiro: Guanabara Koogan, 1983:725-31.
34. Toro G, Roman GC. Cerebral malaria: a disseminated vasculomy-elinopathy. Arch Neurol 1978;35:271-5.
35. Bahemuka M, Murungi H. Tuberculosis of the nervous system: a clinical, radiological, and pathological study of 39 consecutive cases in Riyadh, Saudi Arabia. J Neurol Sci 1989;90:67-76.
36. Teoh R, Humphries MJ, O'Mahoney SG. Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a report of 10 patients and review of the literature. Q J Med 1987;63:449-60.
37. Bharucha NE, Bhabha SK, Bharucha EP. Fungal and parasitic infections. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in clinical practice. Boston: Butterworth-Heinemann, 1991:1120-31.
38. Vyravanathan S, Senanayake N. Tuberculosis presenting with hemiplegia. J Trop Med Hyg 1979;82:38-40.
39. Lorber J. Longterm follow-up of 100 children who recovered from tuberculous meningitis. Pediatrics 1961;28:778-82.
40. Donner M, Wasz-Hockert O. Late neurological sequelae of tuberculous meningitis. Acta Pediatr 1962;51(Suppl 141):34-8.
41. Dastur DK, Udani PM. Pathology and pathogenesis of tuberculous encephalopathy. Acta Neuropathol 1966;5:311-26.
42. Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988;38:1407-10.
43. Pomeroy SL, Holmes SJ, Dodge PR, Feign RD. Seizures and other neurologic sequelae of bacterial meningitis in children. N Engl J Med 1990;323:1651-7.
44. Weaver OM, Pieper S, Kurland R. Sequelae of the arthropod-borne encephalitides: V. Japanese encephalitis. Neurology 1958;8:888-9.
45. Monath TP. Japanese encephalitis - a plague of the Orient. N Engl J Med 1988;319:641-3.
46. Gourie-Devi M, Deshpande DH. Japanese encephalitis. In: Prasad LS, Kulczycki LL, eds. Paediatric problems. New Delhi: S Chand, 1982:340-56.
47. Poneprasert B. Japanese encephalitis in children in northern Thailand. Southeast Asian J Trop Med Public Health 1989;20:599-603.
48. Sotelo J, Garcia E, Rubio-Donnadieu F. Granuloma en parenquima cerebral: un modelo humano para el estudio de epilepsia. Gac Med Mex 1989;125:31-5.
49. Monteiro L, Coelho T, Stocker A. Neurocysticercosis - a review of 231 cases. Infection 1992;20:61-5.
50. Commission on Classification and Terminology of the International League Against Epilepsy. Proposed revision of clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:480-501.
51. Escobar A, Nieto D. Cysticercosis. In: Minkler J, ed. Pathology of the nervous system. Vol 3. New York: McGraw-Hill, 1972:2507-15.
52. Williams G, Lüders H, Brickner A. Interobserver variability in EEC interpretation. Neurology 1985;35:1714-9.
53. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms: study of 753 cases. Arch Intern Med 1985;145:442-5.
54. Costa JM. Teste imunoenzimático (ELISA) no diagnóstico da neurocisticercose. Arq Neuropsiquiatr 1986;44:15-31.
55. Vianna LG, Costa-Cruz JM, Macedo V, et al. Estudo comparativo dos testes imunoenzimáticos ELISA-G e ELISA-M, imunofluorescéncia indireta e fixação do complemento no diagnóstico da cisticercose humana. Arq Neuropsiquiatr 1992;50:302-8.
56. Livramento JA, Costa JM, Machado LR, et al. ELISA (IgG e IgM) no LCR e soro na neurocisticercose em tratamento com praziquantel. Arq Neuropsiquiatr 1985;43:265-74.
57. Spina França A, Livramento JA, Machado LR. Cysticercosis of the central nervous system and cerebrospinal fluid. Arq Neuropsiquiatr 1993;51:16-20.
58. Wilson M, Bryan RT, Fried JA, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991;164:1007-8.
59. Meira DA. Clínica de doenças tropicais e infecciosas. São Paulo: Editora Interlivros, 1991:421-3.
60. Prata A. Esquistossomose mansoni. In: Veronesi R, ed. Doenças infecciosas e parasitárias. Rio de Janeiro: Guanabara Koogan, 1991:838-55.
61. Mott KE, Dixon H. Collaborative study on antigens for immunodiagnosis of schistosomiasis. Bull WHO 1982;60:719-53.
62. US Congress Office of Technology Assessment. Status of biomedical research and related technology for tropical diseases. OTA-H-258. Washington DC: US Government Printing Office, 1985: 153-77.
63. Zickler F, Smith PG, Luquetti AO, et al. Mass screening for Trypanosoma cruzi infections using the immunofluorescence, ELISA and haemagglutination tests on serum samples and on blood eluates from filter-paper. Bull WHO 1990;68:465-71.
64. Spina França A, Livramento JA, Machado LR, et al. Anticorpos a Trypanosoma cruzi no liquido cefaloraqueano. Arq Neuropsiquiatr 1988;46:374-8.
65. World Health Organization. Malaria diagnosis: memorandum from a WHO meeting. Bull WHO 1988;66:575-94.
66. Ferreira AW. Immunodiagnostico de la malaria. In: Antuñano FJL, Schmunis G, eds. Diagnostico de la malaria. Washington: Organizacion Panamericana de la Salud, 1988; Publicacion cientifica n. 512:65-75.
67. World Health Organization. Epidemiology of onchocerciasis: technical report series. Geneva: WHO, 1976:597.
68. Kipp W, Burham G, Kamugisha J. Improvement in seizures after ivermectin. Lancet 1992;340:789-90.
69. Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696-701.
70. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 cases. Neurology 1992;42:389-98.
71. World Health Organization, Division of Mental Health. Initiative of support to people with epilepsy. Doc. WHO/ MNH/MND//90.3. Geneva: WHO, 1990.
72. Bittencourt PRM, Gracia CM, Martins R, Fernandas AG, Diekmann HW, Jung W. Phenytoin and carbamazepine decrease oral bioavailability of praziquantel. Neurology 1992;42:492-6.